FK506 in bone marrow transplantation.
Hemenway
C
C
D000591:Amino Acid Isomerases / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D019703:Calcineurin; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors*; D002352:Carrier Proteins / Q000378:metabolism; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000378:metabolism; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control*; D006360:Heat-Shock Proteins / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D019696:Peptidylprolyl Isomerase; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors*; D011485:Protein Binding; D016559:Tacrolimus / Q000494:pharmacology / Q000627:therapeutic use*; D022021:Tacrolimus Binding Proteins
D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D006360:Heat-Shock Proteins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D010749:Phosphoprotein Phosphatases; D000591:Amino Acid Isomerases; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus